HighVista Strategies’s Guardant Health GH Stock Holding History

HighVista Strategies’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Sell	15,419 -7,938	-34%	-$863K	0.53%	51
2026 Q1	$2.16M	Sell	23,357 -13,401	-36%	-$1.35M	0.6%	54
2025 Q4	$3.75M	Sell	36,758 -27,825	-43%	-$2.49M	0.97%	34
2025 Q3	$4.04M	Buy	64,583 +36,318	+128%	+$1.98M	0.99%	27
2025 Q2	$1.47M	Sell	28,265 -23,453	-45%	-$1.05M	0.54%	67
2025 Q1	$2.2M	Sell	51,718 -42,400	-45%	-$1.83M	0.85%	29
2024 Q4	$2.88M	Buy	+94,118	New	+$2.65M	1.07%	23

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

HighVista Strategies's GH Position: Q2 2026 in Review

HighVista Strategies reduced its Guardant Health (GH) stake by 34% in Q2 2026, selling an estimated $863K and leaving 15,419 shares worth $2.31M. The position accounts for 0.53% of the portfolio, ranked #51.

HighVista Strategies first reported a position in GH in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.04M in Q3 2025. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

HighVista Strategies held 15,419 shares of Guardant Health worth $2.31M as of Q2 2026.
HighVista Strategies sold 7,938 Guardant Health shares in Q2 2026, an estimated $863K.
Guardant Health made up 0.53% of HighVista Strategies's portfolio in Q2 2026, its #51 holding.
HighVista Strategies first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
HighVista Strategies's Guardant Health position peaked at $4.04M in Q3 2025.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.